Skip to main content

Table 5 Analysis of genotypes of all SNVs at different FEV1 predicted values in COPD patients

From: Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population

SNV ID

Model

Genotype

FEV1 predicted, n

OR(95%CI)

p

 ≥ 50%

 < 50%

ANO3/MUC15 rs15783

Codominant

A/A

167

36

1

 

A/G

210

52

0.88(0.55–1.41)

0.584

G/G

65

11

1.29(0.62–2.70)

0.497

Dominant

A/A

167

36

1

 

G/G, A/G

275

63

0.95(0.60–1.49)

0.819

Recessive

A/A, A/G

377

88

1

 

G/G

65

11

1.39(0.71–2.76)

0.340

Additive

–

–

–

1.06(0.76–1.46)

0.743

Allele

A

544

124

1

 

G

340

74

1.05(0.77–1.45)

0.746

COL4A4 rs1800517

Codominant

A/A

125

32

1

 

A/G

213

42

1.33(0.80–2.22)

0.276

G/G

103

25

1.08(0.60–1.95)

0.792

Dominant

A/A

125

32

1

 

G/G, A/G

316

67

1.24(0.77–1.98)

0.376

Recessive

A/A, A/G

338

74

1

 

G/G

103

25

0.91(0.55–1.51)

0.720

Additive

–

–

–

1.06(0.78–1.43)

0.731

Allele

A

463

106

1

 

G

419

92

1.06(0.78–1.44)

0.725

RRBP1 rs11960

Codominant

A/A

134

36

1

 

A/G

221

46

1.33(0.81–2.17)

0.259

G/G

85

17

1.40(0.74–2.65)

0.306

Dominant

A/A

134

36

1

 

G/G, A/G

306

63

1.346(0.85–2.14)

0.207

Recessive

A/A, A/G

355

82

1

 

G/G

85

17

1.18(0.66–2.10)

0.570

Additive

–

–

–

1.21(0.88–1.66)

0.248

Allele

A

489

118

1

 

G

391

80

1.20(0.88–1.65)

0.250

KLK1 rs5516

Codominant

G/G

231

58

1

 

G/C

176

34

1.30(0.82–2.08)

0.278

C/C

31

7

1.19(0.49–2.85)

0.702

Dominant

G/G

231

58

1

 

C/C, G/C

207

41

1.28(0.82–2.00)

0.279

Recessive

G/G, G/C

407

92

1

 

C/C

31

7

1.07(0.45–2.52)

0.877

Additive

–

–

–

1.18(0.83–1.70)

0.357

Allele

G

638

150

1

 

C

238

48

1.18(0.83–1.70)

0.356

  1. P values were calculated by logistic regression analysis, after adjusting for age, gender, and BMI
  2. FEV1 Forced expiratory volume in 1 s, SNV Single nucleotide variation, OR Odds Ratio, 95%CI 95% confidence interval